ADSTILADRIN
NDC 55566-1050, nadofaragene firadenovec-vncg, suspension, from Ferring Pharmaceuticals Inc..
- Product NDC
- 55566-1050
- Status
- Listed
- Labeler
- Ferring Pharmaceuticals Inc.
- Dosage form
- SUSPENSION
- Route
- INTRAVESICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125700
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NADOFARAGENE FIRADENOVEC300000000000 {VP}/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55566-1050-1 | 55566105001 | 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL (55566-1050-0) |
| 55566-1050-2 | 55566105002 | 20 mL in 1 VIAL (55566-1050-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5ca20ed4-da4f-463c-ac2a-ccd6ab3774faMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=55566-1050
Use it
Look up 55566-1050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55566-1050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.